1. FOXO transcription factor family in cancer and metastasis
   Yannasittha Jiramongkol et al, 2020, Cancer and Metastasis Reviews CrossRef
2. Insights into the Biological Evaluation of Pterocarpanquinones and Carbapterocarpans with Anti-tumor Activity against MDR Leukemias
   Vivian M. Rumjanek et al, 2019, Anti-Cancer Agents in Medicinal Chemistry CrossRef
3. Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
   Roberto Mattioli et al, 2023, Molecular Aspects of Medicine CrossRef
4. Preclinical Studies Evaluating Subacute Toxicity and Therapeutic Efficacy of LQB-118 in Experimental Visceral Leishmaniasis
   Edézio Ferreira Cunha-Júnior et al, 2016, Antimicrobial Agents and Chemotherapy CrossRef
5. Biomarkers in Hematological Malignancies: A Review of Molecular Testing in Hematopathology
   Mohammad Hussaini, 2015, Cancer Control CrossRef
6. In vitro and in vivo antineoplastic and immunological effects of pterocarpanquinone LQB-118
   Eduardo J. Salustiano et al, 2016, Investigational New Drugs CrossRef
7. Analysis of the Mechanisms of Action of Naphthoquinone-Based Anti-Acute Myeloid Leukemia Chemotherapeutics
   Michelle H. Lee et al, 2019, Molecules CrossRef
8. The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance
   Shang Yao et al, 2018, Seminars in Cancer Biology CrossRef
9. 11a-N-Tosyl-5-deoxi-pterocarpan, LQB-223, a novel compound with potent antineoplastic activity toward breast cancer cells with different phenotypes
   Lauana Greicy Tonon Lemos et al, 2016, Journal of Cancer Research and Clinical Oncology CrossRef
10. Second-generation pterocarpanquinones: synthesis and antileishmanial activity
    Viviane dos Santos Faiões et al, 2018, Journal of Venomous Animals and Toxins including Tropical Diseases CrossRef
11. Pterocarpan scaffold: A natural lead molecule with diverse pharmacological properties
    Chelliah Selvam et al, 2017, European Journal of Medicinal Chemistry CrossRef